FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely obstetrics and transplantology, and concerns therapeutic abortion in renal graft recipients. That is ensured by introducing the following changes to the three-component immune suppression pattern. A dose of cyclosporine is corrected with regard to the blood concentration of this preparation, the therapeutic dose of cyclosporine is 95-120 ng/ml; a dose of methylprednisolone is increased to 15 mg/day three days prior to therapeutic abortion, and thereafter reduced within a month to initial values; the antibacterial therapy is prescribed for 3-5 days.
EFFECT: implementation of the method allows considerably reducing rates of infectious-inflammatory complications and avoiding development of acute graft rejection.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF LABOUR MANAGEMENT IN PREGNANT WOMEN WITH TRANSPLANTED KIDNEY | 2010 |
|
RU2419428C1 |
METHOD FOR PREVENTING CADAVER KIDNEY GRAFT REJECTION | 2011 |
|
RU2456615C1 |
METHOD FOR RECOMBINANT ERYTHROPOIETIN THERAPY OF ANAEMIA IN PREGNANT RECIPIENTS OF RENAL GRAFT | 2010 |
|
RU2414911C1 |
METHOD FOR PREVENTION AND TREATMENT OF RENAL GRAFT REJECTION | 2013 |
|
RU2508924C1 |
METHOD FOR PREVENTION OF GRAFT KIDNEY GRAFT REJECTION | 2018 |
|
RU2688172C1 |
METHOD OF SELECTING RECIPIENT IN CASE OF CORPSE KIDNEY TRANSPLANTATION | 2010 |
|
RU2425625C1 |
METHOD FOR PREDICTION OF RISK OF COMPLICATIONS OF CADAVERIC LIVER TRANSPLANTATION IN RECIPIENTS | 2010 |
|
RU2424529C1 |
METHOD OF SELECTING THE IMMUNOSUPPRESSION REGIME TO CHILDREN OF EARLY AGE IN A REMOTE PERIOD AFTER TRANSPLANTATION OF THE LIVER | 2015 |
|
RU2619216C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF CRITICAL CONDITIONS OF WOMEN DURING CHILDBEARING AND DURING THE PUERPERIUM | 2017 |
|
RU2647459C1 |
DIAGNOSTIC METHOD FOR RENAL ALLOGRAFT REJECTION | 2007 |
|
RU2348932C1 |
Authors
Dates
2012-01-10—Published
2010-01-14—Filed